Influence of methodological and patient factors on serum NMDAR IgG antibody detection in psychotic disorders: a meta-analysis of cross-sectional and case-control studies.
Cullen, A. E., Palmer-Cooper, E. C., Hardwick, M., Vaggers, S., Crowley, H., Pollak, T. A., & Lennox, B. R.
The Lancet Psychiatry 8.2 (2021): 109-120.
Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2)
Lennox B, Yeeles K, Jones PB, Zandi M, Joyce E, Yu L-M, Tomei G, Pollard R, Vincent S-A, Shimazaki M, Cairns I, Dowling F, Kabir T, Barnes TRE, Lingford Hughes A, Hosseini AA, Harrower T, Buckely C, Coles A.
Trials, (2019), 20:331
Study of immunotherapy in antibody positive psychosis: feasibility and acceptability (SINAPPS1)
B Lennox, G Tomei, S-A Vincent, K Yeeles, R Pollard, EC Palmer-Cooper, P Jones, M Zandi, A Coles.
J Neurol Neurosurg Psychiatry Published Online First: (11 June 2018). doi: 10.1136/jnnp-2018-318124
Psychosis: an autoimmune disease?
A Al-Diwani, T Pollak, S Irani, B Lennox
Immunology, (2017) (epub ahead of print) DOI: 10.1111/imm.12795
Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case-control study
B Lennox, EC Palmer-Cooper, T Pollak, J Hainsworth, J Marks, L Jacobson, B Lang
The Lancet Psychiatry, 2016, 4 (1).
Behavioural and molecular endophenotypes in psychotic disorders reveal heritable abnormalities in glutamatergic neurotransmission
L Scoriels, RM Salek, E Goodby, D Grainger, AM Dean, JA West, JL Griffin
Translational psychiatry, 2015, 5 (3)
Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment
GM Khandaker, L Cousins, J Deakin, BR Lennox, R Yolken, PB Jones
The Lancet Psychiatry, 2015, 2 (3), 258-270
N-methyl D-Aspartate receptor autoantibodies in psychiatric illness
MS Zandi, B Lennox, A Vincent
Biological Psychiatry, 2015
The Oxford Experience: Clinical Features And Outcomes of 25 NMDAR-Ab Positive Patients Including Those With Atypical Presentations (P5. 189)
K Morris, C Buckley, B Lennox, Y Hacohen, E Coutinho, A Vincent
Neurology 82 (10 Supplement), 2014, P5. 189-P5. 189
Autoimmune encephalitis: a potentially treatable cause of mental disorder
H Rickards, S Jacob, B Lennox, T Nicholson
Advances in psychiatric treatment, 2014, 20 (2), 92-100
Immunotherapy for patients with acute psychosis and serum N-Methyl d-Aspartate receptor (NMDAR) antibodies: A description of a treated case series
MS Zandi, JB Deakin, K Morris, C Buckley, L Jacobson, L Scoriels,
Schizophrenia Research, 2014
Clinical relevance of serum antibodies to extracellular N-methyl-d-aspartate receptor epitopes
MS Zandi, RW Paterson, MA Ellul, L Jacobson, A Al-Diwani, JL Jones
J Neurology, Neurosurgery & Psychiatry, 2014
Young people's views of UK mental health services
J Plaistow, K Masson, D Koch, J Wilson, RM Stark, PB Jones, BR Lennox
Early intervention in psychiatry, 2014, 8 (1), 12-23
Movement disorders and psychiatry. Five new things.
G Cummins, M Zandi, RA Barker
Neurology Clinical Practice, 2014
Recent advances in the neuroimmunology of cell-surface CNS autoantibody syndromes, Alzheimer's disease, traumatic brain injury and schizophrenia
E Needham, MS Zandi
Journal of Neurology, 2014
Long term remission with rituximab in refractory leucine-rich glioma inactivated 1 antibody encephalitis
JWL Brown, PJ Martin, JW Thorpe, AW Michell, AJ Coles, AL Cox
Journal of Neuroimmunology, 2014
Antibodies to the N-Methyl-D-Aspartate Receptor and Other Synaptic Proteins in Psychosis
J Deakin, BR Lennox, MS Zandi
Biological psychiatry, 2014, 75 (4), 284-291
Functional dysconnectivity of corticostriatal circuitry as a risk phenotype for psychosis
A Fornito, BJ Harrison, E Goodby, A Dean, C Ooi, PJ Nathan, BR Lennox
JAMA psychiatry, 2013, 70 (11), 1143-1151
Psychotic symptoms in young people warrant urgent referral.
J Deakin, B Lennox
The Practitioner, 2013, 257 (1759), 25-8, 3
Defining and treating leucine-rich glioma inactivated 1 antibody associated autoimmunity
Brain, 2013, 136 (10), 2933-2935
Clinical relevance of positive voltage-gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre
RW Paterson, MS Zandi, R Armstrong, A Vincent, JM Schott
Journal of Neurology, Neurosurgery & Psychiatry, 2013
Antibody-mediated encephalitis: a treatable cause of schizophrenia
BR Lennox, AJ Coles, A Vincent
The British Journal of Psychiatry, 2012, 200 (2) 92-94
Two interesting cases of MMDAR enchepalitis and a typical but seronegative case with ovarian teratoma
M Ellul, S Sawcer, AJ Coles, MS Zandi
Journal of Neurology, Neurosurgery & Psychiatry, 2012, 83 (Suppl 2), A7-A7
Disease-relevant autoantibodies in first episode schizophrenia
MS Zandi, SR Irani, B Lang, P Waters, PB Jones, P McKenna, AJ Coles,
Journal of neurology, 2011, 258 (4), 686-688
POI06 Rituximab in neuropsychiatric systemic lupus erythematosus: a retrospective study of the Cambridge experience
M Zandi, F Catapano, S Burns, FC Hall, KGC Smith, DRW Jayne,
Journal of Neurology, Neurosurgery & Psychiatry, 2010, 81 (11), e54-e54
N-methyl-D-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes
SR Irani, K Bera, P Waters, L Zuliani, S Maxwell, MS Zandi, MA Friese, ...
Brain, 2010, 133 (6), 1655-1667